2024 annual financial data

Ovid Therapeutics 2024 Net margin

Direct answer

Net margin was -4,670.14%.

Operating income was -61.89M USD and net income was -26.43M USD.
Operating cash flow was -55.96M USD.

Get free Ovid Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
566,000 USD
Operating income
-61.89M USD
Net income
-26.43M USD
Operating cash flow
-55.96M USD